Published in N Engl J Med on September 19, 1991
Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol (1995) 2.33
Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma. J Invest Dermatol (2016) 1.01
Integrating pathway analysis and genetics of gene expression for genome-wide association study of basal cell carcinoma. Hum Genet (2011) 0.99
Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol (2007) 0.97
Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol (2012) 0.88
Duality of the immune response in cancer: lessons learned from skin. J Invest Dermatol (2014) 0.84
The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study. J Invest Dermatol (2014) 0.82
Photoimmunology. Dermatol Clin (2014) 0.80
Immunogenetic factors in skin cancer. N Engl J Med (1991) 0.79
The development of squamous cell carcinoma in a patient after kidney transplantation: a case report. Postepy Dermatol Alergol (2013) 0.78
Skin cancer and HLA antigens. N Engl J Med (1992) 0.76
HLA Antigen Profile Differences in Patients with SCC (Squamous Cell Carcinoma) In-Situ /Actinic Keratosis and Invasive SCC: Is There a Genetic Succeptibility for Invasive SCC Development? Eurasian J Med (2009) 0.75
Skin cancer and HLA antigens. N Engl J Med (1992) 0.75
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis (1989) 6.52
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet (1994) 5.58
Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med (1995) 5.16
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet (1995) 5.10
Genetic influence on cytokine production and fatal meningococcal disease. Lancet (1997) 4.89
QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation (1991) 4.37
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ (2009) 4.18
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet (1992) 4.15
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med (1996) 4.11
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet (1995) 4.01
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet (1992) 3.58
Case reports in an evidence-based world. J R Soc Med (1999) 3.55
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
Is publication bias a medical problem? Lancet (1993) 3.04
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood (1995) 2.96
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet (1995) 2.79
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med (1993) 2.70
Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983. Br J Cancer (1990) 2.68
Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ (1994) 2.54
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group. Lancet (1998) 2.42
Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol (1993) 2.40
Osteoarthritis and obesity in the general population. A relationship calling for an explanation. J Rheumatol (1988) 2.39
Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol (1984) 2.38
Antipsychotic medication and venous thrombosis. Br J Psychiatry (2001) 2.37
Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol (1995) 2.33
Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet (1991) 2.31
Bungee-jumping and design of experiments. Lancet (1992) 2.31
Mortality in hereditary antithrombin-III deficiency--1830 to 1989. Lancet (1991) 2.31
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet (1996) 2.30
New public health and old rhetoric. BMJ (1994) 2.18
Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) Blood (1995) 2.09
Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods (1993) 2.08
Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation (1990) 2.07
Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis (1990) 2.07
No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: the Leiden 85-plus study. Eur J Clin Invest (2002) 2.07
Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol (1997) 2.03
Psychiatric disorders in relation to medical illness among patients of a general medical out-patient clinic. Psychol Med (1993) 2.01
Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum (1990) 2.01
Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands. Lancet (1996) 1.99
Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med (1999) 1.95
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol (1996) 1.86
Prospective or retrospective: what's in a name? BMJ (1991) 1.82
Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol (1984) 1.75
Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation (2001) 1.65
The Leiden Thrombophilia Study (LETS). Thromb Haemost (1997) 1.65
Should we abandon statistical modeling altogether? Am J Epidemiol (1987) 1.64
Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int (2007) 1.63
Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands. Diabetologia (2002) 1.63
Usefulness of patient interview in bleeding disorders. Arch Intern Med (1995) 1.62
The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up. Ann Rheum Dis (1983) 1.61
Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA (1986) 1.59
Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood (1995) 1.58
Pregnancy and severe aplastic anaemia: causal relation or coincidence? . Br J Haematol (1998) 1.56
Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol (1998) 1.54
Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr (2000) 1.53
Treatment of eczema herpeticum with acyclovir. Arch Dermatol (1983) 1.52
Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy. Nephrol Dial Transplant (1996) 1.52
Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association. Arch Intern Med (1995) 1.52
Relation between smoking and skin cancer. J Clin Oncol (2001) 1.50
The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum (1996) 1.50
Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation (1997) 1.48
Impact of the Banff '97 classification for histological diagnosis of rejection on clinical outcome and renal function parameters after kidney transplantation. Transplantation (2000) 1.48
Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis (1989) 1.48
The role of compliance as a cause of instability in oral anticoagulant therapy. Br J Haematol (1997) 1.48
Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab (2007) 1.47
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies]. Internist (Berl) (2008) 1.47
Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant (2001) 1.47
Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) (1997) 1.46
Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Br J Rheumatol (1992) 1.46
In defense of Farr and Nightingale. Ann Intern Med (1996) 1.46
The determination of lipids and proteins in suction blister fluid. J Invest Dermatol (1979) 1.46
Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro. Transplantation (2001) 1.46
Effect of danaparoid sodium on hard exudates in diabetic retinopathy. Lancet (1997) 1.46
Renal retransplantation of children: is a policy 'first cadaver donor, then live donor' an acceptable option? Pediatr Transplant (2001) 1.46
Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood (1993) 1.46
Competing interests and controversy about third generation oral contraceptives. BMJ readers should know whose words they read. BMJ (2000) 1.45
On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol (1991) 1.44
Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum (1992) 1.44
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods (1994) 1.43
Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist. Transplantation (1999) 1.43
Renal allograft rejection and antibodies to epithelial cells. Lancet (1992) 1.42
Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. Transplantation (2000) 1.42
Maintaining privacy and the health of the public. Should not be seen as in opposition. BMJ (1998) 1.42
Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens. Transplantation (2001) 1.41
[Epoetin-induced pure red-cell aplasia]. Ned Tijdschr Geneeskd (2004) 1.41
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS). Thromb Haemost (1994) 1.41
Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy. J Rheumatol (1996) 1.40